Examining the link between adiponectin levels and heart and brain diseases in Chinese individuals

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the concentration, activity, and isoforms of serum adiponectin in a Chinese population over a five-year follow-up period. It aims to establish correlations between adiponectin levels and the incidence of myocardial and cerebral infarctions. The study focuses on understanding how adiponectin, a protein with anti-inflammatory and vascular protective properties, may serve as a novel risk factor for cardiovascular and cerebrovascular diseases. Participants will be monitored for changes in their health related to these conditions throughout the study duration.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* available for 5 years of follow-up study

Exclusion Criteria:

* Death caused other than cardiovascular and cerebralvascular diseases till the study ends
* Floating Population
* Pregnancy, lactation, or child bearing women
* Tumor
* Active hepatic disease or hepatic dysfunction, or AST/ALT \> 1.5UNL
* Severe renal dysfunction(Scr \> 3 mg/dl or 264μmol/L)
* Patients with any condition which, in the investigator's judgment, might increase the risk to the subject for any adverse event or abnormal laboratory finding

Where it's running

• Xijing Hospital
  Xi'an, Shaanxi, China Recruiting

Study contacts

• Study coordinator: Ling Tao, M.D Ph.D
• Email: lingtao2006@gmail.com
• Phone: +86-15002955798

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using colchicine and ticagrelor to prevent ischemic stroke in patients with atherosclerosis

  This study is testing if a combination of low-dose colchicine and ticagrelor can help prevent future strokes in people with atherosclerosis who have already had an ischemic stroke.

  Recruiting Phase 3 Assistance Publique - Hôpitaux de Paris · Paris, Paris · NCT05476991

• Heart@Home: Safe, at-home care for people with acute heart problems compared with hospital care

  This trial tests whether hospital-level care at home can safely and effectively treat adults with acute heart conditions who would normally be in the hospital.

  Recruiting Tel-Aviv Sourasky Medical Center · Tel Aviv · NCT07913152

• Digital cardiac rehab to help heart attack patients improve function

  A digital health–supported cardiac rehabilitation program is being tested to see if it helps people after a heart attack improve fitness and stay engaged with rehab, compared with standard outpatient rehab.

  Recruiting Cairo University · Minya, Minya Province · NCT07867197

• NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa

  This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.

  Recruiting University of Eastern Finland · Savonlinna · NCT07820800

• See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease

  In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.

  Recruiting at 2 sites Phase 4 Odense University Hospital · Copenhagen and 1 other locations · NCT07795398

• Erlangen Stroke Registry: A long-running look at stroke in a German community

  This registry is testing how stroke cases are collected and followed over time in Erlangen to understand how many people are affected and how care evolves.

  Recruiting at 3 sites University of Erlangen-Nürnberg Medical School · Erlangen and 2 other locations · NCT07771335

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.